Notification No. FEMA. 296/2014-RB dated 3rd March, 2014, vide G.S.R. No. 270(E) dated 7th April 2014
Foreign Direct Investment in Pharmaceuticals sector – clarification
This circular states that, with immediate effect, the ‘non-compete’ clause will not be permitted in the case of FDI in Pharmaceuticals sector, except with FIPB approval. Hence, whenever parties want to incorporate the ‘non-compete’ clause in their agreements FDI will have to be under the Approval Route.